Is INZY or XYLD a better dividend investment in 2026?

INZY currently yields 50.00% with a 5% 5-year dividend growth rate. XYLD yields 10.98% with 0.5% growth. The better choice depends on your goal: INZY offers higher current income.

What is the dividend yield difference between INZY and XYLD?

INZY has a forward dividend yield of 50.00% ($2.00/share annually). XYLD yields 10.98% ($4.30/share annually). The yield gap is 39.02 percentage points.

Home › Compare › INZY vs XYLD

INZY vs XYLD: Dividend Comparison 2026

INZY yields 50.00% · XYLD yields 10.98%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 INZY wins by $368.7K in total portfolio value

INVESTMENT

TIME HORIZON10 years

INZY

● Live price

50.00%

Share price

$4.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$394.0K

Annual income

$79,849.97

Full INZY calculator →

XYLD

Global X S&P 500 Covered Call ETF

● Live price

10.98%

Share price

$39.13

Annual div

$4.30

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$25.3K

Annual income

$3,219.02

Full XYLD calculator →

Portfolio growth — INZY vs XYLD

📍 INZY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	INZY	XYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, INZY + XYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

INZY pays

XYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

INZY

Annual income on $10K today (after 15% tax)

$4,250.00/yr

After 10yr DRIP, annual income (after tax)

$67,872.47/yr

XYLD

Annual income on $10K today (after 15% tax)

$933.63/yr

After 10yr DRIP, annual income (after tax)

$2,736.17/yr

At 15% tax rate, INZY beats the other by $65,136.31/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of INZY + XYLD for your $10,000?

INZY: 50%XYLD: 50%

100% XYLD50/50100% INZY

Portfolio after 10yr

$209.6K

Annual income

$41,534.49/yr

Blended yield

19.81%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on INZY right now

INZY

Analyst Ratings

Buy

Hold

Consensus: Buy

Price Target

$12.00

+200.0% upside vs current

Range: $4.00 — $16.00

Altman Z

-6.5

Piotroski

2/9

XYLD

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

INZY buys

XYLD buys

No recent congressional trades found for INZY or XYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricINZYXYLD

Forward yield	50.00% ✓	10.98%
Annual dividend / share	$2.00	$4.30 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$394.0K ✓	$25.3K
Annual income after 10y	$79,849.97 ✓	$3,219.02
Total dividends collected	$314.4K ✓	$19.6K
Payment frequency	quarterly	monthly
Sector	Stock	ETF

Year-by-year: INZY vs XYLD ($10,000, DRIP)

Year	INZY Portfolio	INZY Income/yr	XYLD Portfolio	XYLD Income/yr	Gap
1← crossover	$15,700	$5,000.00	$10,818	$1,098.39	+$4.9K → INZY
2	$24,135	$7,336.45	$11,738	$1,222.51	+$12.4K → INZY
3	$36,365	$10,540.42	$12,774	$1,364.64	+$23.6K → INZY
4	$53,753	$14,842.48	$13,944	$1,527.86	+$39.8K → INZY
5	$78,020	$20,504.11	$15,270	$1,715.87	+$62.8K → INZY
6	$111,295	$27,813.68	$16,775	$1,933.09	+$94.5K → INZY
7	$156,166	$37,080.39	$18,490	$2,184.87	+$137.7K → INZY
8	$215,724	$48,626.29	$20,450	$2,477.63	+$195.3K → INZY
9	$293,602	$62,776.77	$22,697	$2,819.19	+$270.9K → INZY
10	$394,004	$79,849.97	$25,280	$3,219.02	+$368.7K → INZY

INZY vs XYLD: Complete Analysis 2026

INZY — Stock

Inozyme Pharma, Inc., a rare disease biopharmaceutical company, engages in developing therapeutics for treating abnormal mineralization impacting the vasculature, soft tissue, and skeleton diseases. The company's lead product candidate is INZ-701, a soluble, recombinant protein to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies, as well as for the treatment of calciphylaxis. It has a license agreement with Yale University for specified therapeutic and prophylactic products. Inozyme Pharma, Inc. was incorporated in 2015 and is headquartered in Boston, Massachusetts.

Full INZY Calculator →

XYLD — ETF

The Global X S&P 500 Covered Call ETF (XYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe S&P 500 BuyWrite Index.

Full XYLD Calculator →

📬

Get this INZY vs XYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

INZY vs SCHD INZY vs JEPI INZY vs O INZY vs KO INZY vs MAIN INZY vs QYLD INZY vs JEPQ INZY vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.